Dane, F. Et Al. 2004. FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens.. 40th Annual Meeting of the American-Society-of-Clinical-Oncology , (Louisiana, United States Of America).

Dane, F., Yumuk, P., Turhal, N., Ekenel, M., Basaran, G., Iyikesici, M., ... Tecimer, C.(2004). FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens. . 40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America

Dane, F Et Al. "FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens.," 40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 2004

Dane, F Et Al. "FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens.." 40th Annual Meeting of the American-Society-of-Clinical-Oncology , Louisiana, United States Of America, 2004

Dane, F. Et Al. (2004) . "FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens.." 40th Annual Meeting of the American-Society-of-Clinical-Oncology , Louisiana, United States Of America.

@conferencepaper{conferencepaper, author={F Dane Et Al. }, title={FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens.}, congress name={40th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Louisiana}, country={United States Of America}, year={2004}}